Jane Street
ERNA icon

Jane Street’s Eterna Therapeutics ERNA Stock Holding History

Jane Street’s Portfolio ERNA Stock Details ERNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4
Closed -$131K – 10459
2021
Q4 		$131K Sell
4
-7
-64% -$381K ﹤0.01% 9092
2021
Q3 		$752K Sell
11
-14
-56% -$1.21M ﹤0.01% 6497
2021
Q2 		$3.37M Buy
+25
New +$3.6M ﹤0.01% 3367

Other funds holding ERNA

Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tradewinds Capital Management Bellingham, Washington $563M AUM 41.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

Jane Street's ERNA Position: Q2 2026 in Review

Jane Street sold out of Eterna Therapeutics (ERNA) in Q2 2026, closing a stake of 1,647 shares — an estimated $8.19K sold.

Jane Street first reported a position in ERNA in Q2 2020 and held it in 6 quarters. The position peaked at $148K in Q3 2021. 9 funds tracked by Wall St. Rank hold ERNA as of Q2 2026.

  • Jane Street reported no remaining Eterna Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 1,647 Eterna Therapeutics shares in Q2 2026, an estimated $8.19K.
  • Jane Street first reported a position in Eterna Therapeutics in Q2 2020 and held it in 6 quarters.
  • Jane Street's Eterna Therapeutics position peaked at $148K in Q3 2021.
  • 9 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.